168 related articles for article (PubMed ID: 12560773)
1. Failure of routine axillary nodal sampling to predict survival outcomes in lymph node-negative (N0) breast cancer.
Bland KI
Ann Surg; 2003 Feb; 237(2):168-70. PubMed ID: 12560773
[No Abstract] [Full Text] [Related]
2. Is axillary dissection needed in node-positive breast cancer?
Greenberg CC; Bafford AC; Golshan M
Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
[TBL] [Abstract][Full Text] [Related]
3. Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less.
Moffat FL
J Surg Oncol; 2005 Feb; 89(2):53-60. PubMed ID: 15660377
[No Abstract] [Full Text] [Related]
4. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
Ahlgren J; Holmberg L; Bergh J; Liljegren G
Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
[TBL] [Abstract][Full Text] [Related]
5. Lower nodal counts in axillary dissection following neoadjuvant chemotherapy: are there implications?
Callcut RA; Breslin TM
Am J Surg; 2006 Jun; 191(6):830-1. PubMed ID: 16720160
[No Abstract] [Full Text] [Related]
6. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
7. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
8. Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept.
Khan SA
J Clin Oncol; 2009 Nov; 27(33):5494-6. PubMed ID: 19826108
[No Abstract] [Full Text] [Related]
9. Sentinel lymph node biopsy in breast cancer: a comprehensive literature review.
Salem A
J Surg Educ; 2009; 66(5):267-75. PubMed ID: 20005499
[TBL] [Abstract][Full Text] [Related]
10. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
[TBL] [Abstract][Full Text] [Related]
11. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
12. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
Samphao S; Eremin JM; El-Sheemy M; Eremin O
Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
14. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.
Noguchi M
Eur J Surg Oncol; 2008 Feb; 34(2):129-34. PubMed ID: 17498911
[TBL] [Abstract][Full Text] [Related]
15. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
16. Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes.
Taras AR; Hendrickson NA; Lowe KA; Atwood M; Beatty JD
Am J Surg; 2010 May; 199(5):625-8. PubMed ID: 20466106
[TBL] [Abstract][Full Text] [Related]
17. Radical axillary dissection in sentinel lymph node biopsy era: it's still a considerable technique in breast cancer management?
Sanguinetti A; Catania A; Docimo G; Avenia N
G Chir; 2010; 31(6-7):344-6. PubMed ID: 20646390
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
19. Axillary nodal yields: a comparison between primary clearance and completion clearance after sentinel lymph node biopsy in the management of breast cancer.
Chakravorty A; Sanmugalingam N; Shrestha A; Thomee E; Rusby J; Roche N; MacNeill F
Eur J Surg Oncol; 2011 Feb; 37(2):122-6. PubMed ID: 21095094
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
